PARP Inhibitors in Breast Cancer: a Short Communication

被引：0
作者：
Gordon R. Daly
Maen Monketh AlRawashdeh
Jason McGrath
Gavin P. Dowling
Luke Cox
Sindhuja Naidoo
Damir Vareslija
Arnold D. K Hill
Leonie Young
机构：
[1] Royal College of Surgeons in Ireland,The Department of Surgery
[2] Beaumont Hospital,The Department of Surgery
来源：
Current Oncology Reports | 2024年 / 26卷
关键词：
PARP inhibitor; Breast cancer; BRCA; Homologous repair deficiency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 113
页数：10
相关论文
共 50 条
  • [41] PARP Inhibitors in Prostate Cancer
    Praveen Ramakrishnan Geethakumari
    Matthew J. Schiewer
    Karen E. Knudsen
    Wm. Kevin Kelly
    Current Treatment Options in Oncology, 2017, 18
  • [42] Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells
    McDonald, Elizabeth S.
    Mankoff, Julia
    Makvandi, Mehran
    Chu, Wenhua
    Chu, Yunxiang
    Mach, Robert H.
    Zeng, Chenbo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 486 (03) : 788 - 795
  • [43] Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer
    van Voss, Marise R. Heerma
    Brilliant, Justin D.
    Vesuna, Farhad
    Bol, Guus M.
    van der Wall, Elsken
    van Diest, Paul J.
    Raman, Venu
    MEDICAL ONCOLOGY, 2017, 34 (03)
  • [44] Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib
    McCann, Kelly E.
    FUTURE ONCOLOGY, 2019, 15 (15) : 1707 - 1715
  • [45] Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer
    Marise R. Heerma van Voss
    Justin D. Brilliant
    Farhad Vesuna
    Guus M. Bol
    Elsken van der Wall
    Paul J. van Diest
    Venu Raman
    Medical Oncology, 2017, 34
  • [46] PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations
    Vanacker, Helene
    Harter, Philipp
    Labidi-Galy, Sana Intidhar
    Banerjee, Susana
    Oaknin, Ana
    Lorusso, Domenica
    Ray-Coquard, Isabelle
    CANCER TREATMENT REVIEWS, 2021, 99
  • [47] PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
    Giannini, Andrea
    Di Dio, Camilla
    Di Donato, Violante
    D'oria, Ottavia
    Salerno, Maria Giovanna
    Capalbo, Giuseppe
    Cuccu, Ilaria
    Perniola, Giorgia
    Muzii, Ludovico
    Bogani, Giorgio
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (09): : 414 - 419
  • [48] PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond
    Menezes, Maria Clara Saad
    Raheem, Farah
    Mina, Lida
    Ernst, Brenda
    Batalini, Felipe
    CANCERS, 2022, 14 (17)
  • [49] New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
    Han, Ye
    Yu, Xiaopeng
    Li, Shuqiang
    Tian, Ye
    Liu, Caigang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] PARP molecular functions and applications of PARP inhibitors in cancer treatment
    Yuhan Guo
    Boyang Fan
    Mo Li
    Genome Instability & Disease, 2023, 4 (3) : 137 - 153
12345